These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 23001860)

  • 1. Treg cells in giant cell arteritis: might they be another target for adjuvant treatment? Comment on the article by Samson et al.
    Fernández-Fernández FJ
    Arthritis Rheum; 2013 Jan; 65(1):289. PubMed ID: 23001860
    [No Abstract]   [Full Text] [Related]  

  • 2. Treg cells in giant cell arteritis: might they be another target for adjuvant treatment? Comment on the article by Samson et al. Reply.
    Samson M; Bonnotte B
    Arthritis Rheum; 2013 Jan; 65(1):289-90. PubMed ID: 23001840
    [No Abstract]   [Full Text] [Related]  

  • 3. Functionally relevant treg cells are present in giant cell arteritis lesions: comment on the article by Samson et al.
    Corbera-Bellalta M; Planas-Rigol E; Espígol-Frigolé G; Lozano E; Cid MC
    Arthritis Rheum; 2013 Apr; 65(4):1133-4. PubMed ID: 23334937
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply: To PMID 22833233.
    Samson M; Janikashvili N; Martin L; Audia S; Bonnotte B
    Arthritis Rheum; 2013 Apr; 65(4):1134-5. PubMed ID: 23334799
    [No Abstract]   [Full Text] [Related]  

  • 5. Th1 and Th17 lymphocytes expressing CD161 are implicated in giant cell arteritis and polymyalgia rheumatica pathogenesis.
    Samson M; Audia S; Fraszczak J; Trad M; Ornetti P; Lakomy D; Ciudad M; Leguy V; Berthier S; Vinit J; Manckoundia P; Maillefert JF; Besancenot JF; Aho-Glele S; Olsson NO; Lorcerie B; Guillevin L; Mouthon L; Saas P; Bateman A; Martin L; Janikashvili N; Larmonier N; Bonnotte B
    Arthritis Rheum; 2012 Nov; 64(11):3788-98. PubMed ID: 22833233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to: ustekinumab inhibits Th1 and Th17 polarisation in a giant-cell arteritis patient by Samson
    Conway R; Fearon U; Molloy ES
    Ann Rheum Dis; 2018 Feb; 77(2):e7. PubMed ID: 28546254
    [No Abstract]   [Full Text] [Related]  

  • 7. Pathogenesis of polymyalgia rheumatica.
    Guggino G; Ferrante A; Macaluso F; Triolo G; Ciccia F
    Reumatismo; 2018 Mar; 70(1):10-17. PubMed ID: 29589398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA antigens in patients with giant cell arteritis and polymyalgia rheumatica.
    Hunder GG; Taswell HF; Pineda AA; Elveback LR
    J Rheumatol; 1977; 4(3):321-3. PubMed ID: 926109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-DR locus antigens in polymyalgia rheumatica and giant cell arteritis.
    Calamia KT; Moore SB; Elveback LR; Hunder GG
    J Rheumatol; 1981; 8(6):993-6. PubMed ID: 6948960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD8 lymphocytes in polymyalgia rheumatica and giant cell arteritis: a reply.
    Arnold MH; Pitzalis C; Corrigall VM; Panayi GS
    Clin Exp Rheumatol; 1994; 12(2):228. PubMed ID: 8039296
    [No Abstract]   [Full Text] [Related]  

  • 11. HLA-DR antigens in polymyalgia rheumatica and giant cell arteritis.
    Gouet D; Alcalay D; Azais I; Alcalay M; Becq-Giraudon B; Sudre Y; Bontoux D
    J Rheumatol; 1985 Jun; 12(3):627-8. PubMed ID: 3862847
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-neutrophil cytoplasm antibodies in giant cell arteritis and polymyalgia rheumatica.
    Meyer O; De Bandt M; Haim T; Kahn MF
    Ann Med Interne (Paris); 1992; 143(7):476. PubMed ID: 1300870
    [No Abstract]   [Full Text] [Related]  

  • 13. Circulating T cell subtypes in polymyalgia rheumatica and giant cell arteritis: variation in the percentage of CD8+ cells with prednisolone treatment.
    Panayi GS
    Ann Rheum Dis; 1994 Apr; 53(4):283. PubMed ID: 8203964
    [No Abstract]   [Full Text] [Related]  

  • 14. Lack of consistent peripheral blood lymphocyte transformation responses in polymyalgia rheumatica and giant cell arteritis.
    Jones JG; Park JR; Hazelman BL; Ward M; Bulgen DY
    J Rheumatol; 1980; 7(6):891-4. PubMed ID: 7205827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum immunoglobulin G4 in giant cell arteritis and polymyalgia rheumatica.
    Burkel M; Arndt F; Schirmer JH; Moosig F; Holle JU
    Clin Exp Rheumatol; 2017; 35 Suppl 103(1):94-97. PubMed ID: 27974093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to cardiolipin and beta 2 glycoprotein I in patients with polymyalgia rheumatica and giant cell arteritis.
    Meyer O; Nicaise P; Moreau S; de Bandt M; Palazzo E; Hayem G; Chazerain P; Labarre C; Kahn MF
    Rev Rhum Engl Ed; 1996 Apr; 63(4):241-7. PubMed ID: 8738442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymyalgia rheumatica and giant cell arteritis: histocompatibility typing and hepatitis-B infection studies.
    Bridgeford PH; Lowenstein M; Bocanegra TS; Vasey FB; Germain BF; Espinoza LR
    Arthritis Rheum; 1980 Apr; 23(4):516-8. PubMed ID: 7370065
    [No Abstract]   [Full Text] [Related]  

  • 18. Increased frequency of HLA-DR3 and DR4 in polymyalgia rheumatica-giant cell arteritis.
    Lowenstein MB; Bridgeford PH; Vasey FB; Germain BF; Espinoza LR
    Arthritis Rheum; 1983 Jul; 26(7):925-7. PubMed ID: 6603224
    [No Abstract]   [Full Text] [Related]  

  • 19. Discontinuation of therapies in polymyalgia rheumatica and giant cell arteritis.
    Muratore F; Pipitone N; Hunder GG; Salvarani C
    Clin Exp Rheumatol; 2013; 31(4 Suppl 78):S86-92. PubMed ID: 24129145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymyalgia rheumatica and giant cell arteritis: circulating immune complexes.
    Espinoza LR; Bridgeford P; Lowenstein M; Bocanegra TS; Vasey FB; Germain BF
    J Rheumatol; 1982; 9(4):556-60. PubMed ID: 6215486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.